CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Johns Hopkins public health and emergency preparedness experts to host first national symposium

Johns Hopkins public health and emergency preparedness experts will host the first national symposium designed to help health care providers and staff better prepare for and react to an "active shooter" in hospitals and other the health care settings.

5 Mar 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Kindred Healthcare consolidated revenues decline 1% to $1.22 billion in Q4 2013

Kindred Healthcare, Inc. today announced its operating results for the fourth quarter and year ended December 31, 2013. The Company continues to benefit from its repositioning strategy through the planned exit from a nursing center and a transitional care hospital and the closure of another nursing center during the fourth quarter of 2013.

20 Feb 2014

Idiopathic pulmonary fibrosis could soon be diagnosed without the need for surgical lung biopsy

People who have suspected idiopathic pulmonary fibrosis without typical patterns on high resolution computed tomography scans could in future be spared the substantial risks of lung biopsy and be given a confident diagnosis of IPF based on clinical and radiological findings alone, according to new research published in The Lancet Respiratory Medicine.

20 Feb 2014

Nanodiamond-drug embedded in contact lenses shows great promise for glaucoma treatment

By 2020, nearly 80 million people are expected to have glaucoma, a disorder of the eye that, if left untreated, can damage the optic nerve and eventually lead to blindness.

19 Feb 2014

NeoStrata announces debut of Vitamin C+ Antiaging Booster

NeoStrata Company, Inc., the creator of the original Glycolic Acid peel, is pleased to announce the debut of Vitamin C+ Antiaging Booster, available February 1, 2014. The NEW dermatologist developed product is the latest and most technologically advanced treatment for helping to smooth wrinkles and brighten dark spots improving skin texture and luminosity.

18 Feb 2014

Researchers reveal inner workings of nanomotor

Our cells produce thousands of proteins but more than one-third of these proteins can fulfill their function only after migrating to the outside of the cell. While it is known that protein migration occurs with the help of various 'nanomotors' that push proteins out of the cell, little is known about their precise mechanical functioning.

6 Feb 2014

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans, and MRIs, ultrasound has seen limited use in cancer treatment due to clarity and resolution issues.

29 Jan 2014

Westone to launch TRU hearing protection earpieces at 2014 NAMM Show

Westone, the leader in high performance audio and in-ear monitoring technology, will launch their TRU™ Custom and Universal hearing protection earpieces at the 2014 NAMM Show.

25 Jan 2014

HD Medical to showcase groundbreaking visual stethoscope at Arab Health exposition

At the upcoming Arab Health exposition in the Australian Pavilion Stand 2H13, HD Medical, Inc. will demonstrate its groundbreaking visual stethoscope ViScope MD featuring the world's first murmur detection capability. This revolutionary stethoscope offers a unique integrated visual display that lets medical professionals perform dynamic auscultation and "see" the heart sounds they hear in real-time visual waveforms. The ViScope MD visual display is complemented by superior high fidelity sound quality for unmatched clarity. HD Medical has invested over a decade refining its proprietary noise reduction technology.

20 Jan 2014

Insurers again extend payment deadlines for customers who signed up for Jan. 1 coverage on exchanges

News outlets in California offer examples of companies that are giving new customers more time to pay their first month's premiums while in Connecticut, one insurer is beginning to get a handle on the crush of enrollment.

16 Jan 2014

Viewpoints: Stop 'bailout' of Obamacare; health law not to blame for all insurance woes; 'theft' of Medicare advantage money

Shrinking revenues and rising costs could bring on the "death spiral" - an unbalanced patient pool forcing huge premium increases (to restore revenue) that would further unbalance the patient pool as the young and healthy drop out. End result? Insolvency

6 Jan 2014

Barriers to joined-up working, insufficient focus on prevention persist in child health services in new NHS

Barriers to joined-up working and an insufficient focus on prevention appear to persist in child health services in the reformed NHS, according to the results of a survey published today.

18 Dec 2013

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a four-year, randomized clinical trial-the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia.

11 Dec 2013

Viewpoints: Optimism about Obamacare; 834 errors; can-you-keep-your-doctor debate

This was the week when liberals decided that it was safe to feel optimistic about Obamacare again. ... A worst-case scenario, in which the website remained unusable well into the new year, seems to have been averted, and with it the danger that insurers or Congressional Democrats would begin to bail on Obamacare entirely.

10 Dec 2013

Scientists identify key factor for limiting inflammatory responses, particularly in skin

Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.

6 Dec 2013

New research offers fresh insights to drug designers searching for better pain treatments

In a technical tour de force, UC San Francisco scientists have determined, at near-atomic resolution, the structure of a protein that plays a central role in the perception of pain and heat.

5 Dec 2013

Cell Therapeutics concludes agreement with GKV-SV regarding reimbursement price of PIXUVRI

Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).

4 Dec 2013

Mutation in alpha-synuclein gene causes increased vulnerability to pesticides, leading to Parkinson's

A team of researchers has brought new clarity to the picture of how gene-environmental interactions can kill nerve cells that make dopamine. Dopamine is the neurotransmitter that sends messages to the part of the brain that controls movement and coordination.

27 Nov 2013

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (AREDS2) clinical centers, executed by the EMMES Corporation and sponsored by Notal Vision Ltd. Tel Aviv, Israel, have been accepted for publication in Ophthalmology.

16 Nov 2013